Rapid Therapeutic Science Laboratories, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RTSL research report →
Price Chart
About the company
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues.
- CEO
- Donal R. Schmidt Jr.
- IPO
- 2017
- Employees
- 3
- HQ
- De Leon, TX, US
Get TickerSpark's AI analysis on RTSL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $883
- P/E
- -0.01
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -58.19
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5.89%
- ROIC
- -22.97%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-23,972+0.0%
- Op Income
- $-83,226
- Net Income
- $-183,296+0.0%
- EPS
- $-0.01+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.84
- RSI (14)
- 0
- Avg Volume
- 36
No earnings-call transcripts are available for RTSL yet.
- Free Float
- 41.8%
- Shares Outstanding
- 8.83M
- Float Shares
- 3.69M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 3, 21 | Justin Scott Suggs | other | 0 |
| Dec 27, 21 | Berrier Sean Paul | other | 2,000,000 |
| Dec 27, 21 | Schmidt Donal Ray Jr. | other | 2,000,000 |
| Aug 27, 21 | Punzi Henry Anthony | other | 0 |
| Aug 27, 21 | Punzi Henry Anthony | other | 0 |
| Aug 3, 21 | Justin Scott Suggs | other | 0 |
| Dec 22, 20 | Berrier Sean Paul | sell | 1,666,667 |
| Dec 22, 20 | Berrier Sean Paul | sell | 2,000,000 |
| Dec 28, 20 | Berrier Sean Paul | sell | 600,000 |
| Dec 2, 20 | Schmidt Donal Ray Jr. | other | 54,600,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RTSL coverage
Recent articles, reports, and earnings notes.
No research on RTSL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RTSL report →